First Hawaiian Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,700
| Closed | -$966K | – | 176 |
|
|
2024
Q4 | $966K | Buy |
14,700
+200
| +1% | +$13.1K | 0.03% | 422 |
|
|
2024
Q3 | $1.02M | Sell |
14,500
-1,000
| -6% | -$70.3K | 0.03% | 418 |
|
|
2024
Q2 | $1.28M | Sell |
15,500
-400
| -3% | -$32.9K | 0.04% | 319 |
|
|
2024
Q1 | $1.39M | Sell |
15,900
-32
| -0.2% | -$2.8K | 0.04% | 316 |
|
|
2023
Q4 | $1.54M | Buy |
15,932
+432
| +3% | +$41.7K | 0.05% | 292 |
|
|
2023
Q3 | $1.37M | Hold |
15,500
| – | – | 0.05% | 298 |
|
|
2023
Q2 | $1.34M | Hold |
15,500
| – | – | 0.04% | 307 |
|
|
2023
Q1 | $1.51M | Hold |
15,500
| – | – | 0.05% | 275 |
|
|
2022
Q4 | $1.6M | Hold |
15,500
| – | – | 0.06% | 254 |
|
|
2022
Q3 | $1.31M | Hold |
15,500
| – | – | 0.05% | 273 |
|
|
2022
Q2 | $1.28M | Hold |
15,500
| – | – | 0.05% | 289 |
|
|
2022
Q1 | $1.2M | Hold |
15,500
| – | – | 0.04% | 328 |
|
|
2021
Q4 | $1.37M | Buy |
+15,500
| New | +$1.37M | 0.04% | 315 |
|
|
2019
Q3 | – | Sell |
-6,300
| Closed | -$540K | – | 820 |
|
|
2019
Q2 | $540K | Sell |
6,300
-2,635
| -29% | -$226K | 0.03% | 428 |
|
|
2019
Q1 | $794K | Buy |
8,935
+200
| +2% | +$17.8K | 0.04% | 306 |
|
|
2018
Q4 | $744K | Sell |
8,735
-100
| -1% | -$8.52K | 0.04% | 295 |
|
|
2018
Q3 | $857K | Buy |
+8,835
| New | +$857K | 0.04% | 307 |
|